Mauna Kea Technologies SAS
PAR:MKEA

Watchlist Manager
Mauna Kea Technologies SAS Logo
Mauna Kea Technologies SAS
PAR:MKEA
Watchlist
Price: 0.506 EUR -2.69%
Market Cap: €24.4m

Relative Value

There is not enough data to reliably calculate the relative value of MKEA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MKEA Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

MKEA Competitors Multiples
Mauna Kea Technologies SAS Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Mauna Kea Technologies SAS
PAR:MKEA
23.5m EUR 1.8 -4.2 -19 -13.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.1B USD 18.6 65.5 50.1 60.7
US
Abbott Laboratories
NYSE:ABT
184.5B USD 4.2 28.3 16 21.9
US
Boston Scientific Corp
NYSE:BSX
139.3B USD 7.2 49.8 29.2 39.7
US
Stryker Corp
NYSE:SYK
136.2B USD 5.6 46.3 22.6 27.4
IE
Medtronic PLC
NYSE:MDT
129.3B USD 3.7 27.1 15.2 22
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD 2.7 34.6 12.7 21.6
DE
Siemens Healthineers AG
XETRA:SHL
47.4B EUR 2 22.2 12.7 17.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.2B USD 13.2 53.7 38.6 42.7
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD 8.1 35 24.9 27.3
US
Resmed Inc
NYSE:RMD
37.5B USD 7.1 26 18.7 20.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Mauna Kea Technologies SAS
PAR:MKEA
Average EV/EBITDA: 24.1
Negative Multiple: -19
N/A N/A
US
Intuitive Surgical Inc
NASDAQ:ISRG
50.1
24%
2.1
US
Abbott Laboratories
NYSE:ABT
16
9%
1.8
US
Boston Scientific Corp
NYSE:BSX
29.2
22%
1.3
US
Stryker Corp
NYSE:SYK
22.6
13%
1.7
IE
Medtronic PLC
NYSE:MDT
15.2
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.7
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.7
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.6
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
24.9
13%
1.9
US
Resmed Inc
NYSE:RMD
18.7
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Mauna Kea Technologies SAS
PAR:MKEA
Average EV/EBIT: 30.2
Negative Multiple: -13.6
N/A N/A
US
Intuitive Surgical Inc
NASDAQ:ISRG
60.7
25%
2.4
US
Abbott Laboratories
NYSE:ABT
21.9
17%
1.3
US
Boston Scientific Corp
NYSE:BSX
39.7
32%
1.2
US
Stryker Corp
NYSE:SYK
27.4
16%
1.7
IE
Medtronic PLC
NYSE:MDT
22
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.6
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.8
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.7
15%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
27.3
14%
2
US
Resmed Inc
NYSE:RMD
20.7
12%
1.7